SEC filings
DaVita (DVA)
Recent filings DaVita made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0000927066All filings on SEC.gov
10-QQuarterly report
Quarterly report
DaVita filed its quarterly report on Form 10-Q, covering its U.S. dialysis and related lab services, U.S. integrated kidney care and ancillary services, and international operations. …
8-KCurrent report
Results of Operations and Financial Condition
DaVita Inc. reported third-quarter 2026 consolidated revenues of $3.578 billion, operating income of $499 million, diluted earnings per share of $3.40, and adjusted diluted earnings per share of $3.82. …
10-QQuarterly report
Quarterly report
DaVita filed its quarterly report with the SEC, disclosing its management discussion and analysis of financial condition and results of operations. The filing describes its U.S. dialysis business, U.S. …
8-KCurrent report
Results of Operations and Financial Condition
DaVita Inc. reported second-quarter 2026 consolidated revenues of $3.554 billion, operating income of $579 million, and diluted earnings per share of $4.02, and provided 2026 guidance for adjusted operating income of $2.15–$2.25 billion…
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow DaVita in Readster
Add DaVita to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.